IMU 9.26% 5.9¢ imugene limited

Ann: Imugene First Patient Dosed in PD1-VAXX Clinical Trial, page-58

  1. 2,103 Posts.
    lightbulb Created with Sketch. 2335
    Hey oxxa,

    Here's the announcement put out on 6 August 2020 announcing that Imugene had received guidance from the US Food and Drug Administration in relation to the "development pathway" for VAXinia (CF33).

    Leslie has intimated that FDA IND approval should be received by the end of the year.

    http://www.aspecthuntley.com.au/docserver/02263638.pdf?fileid=02263638&datedir=20200806&edt=MjAyMC0xMi0wMSsxMjo0MjozNSs0ODArMTA3ODkzK2FuZHJld3dlc3QrcmVkaXJlY3QraHR0cDovL3d3dy5hc3BlY3RodW50bGV5LmNvbS5hdS9pbWFnZXNpZ25hbC9lcnJvcnBhZ2VzL3BkZnRpbWVvdXQuaHRtbCtodHRwOi8vd3d3LmFzcGVjdGh1bnRsZXkuY29tLmF1L2ltYWdlc2lnbmFsL2Vycm9ycGFnZXMvcGRmZGVsYXllZC5qc3A=
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.